Categories: All postsAnalysts

Buy Air Canada ahead of Q3 earnings, Paradigm Capital says

Ahead of Air Canada’s (Air Canada Stock Quote, Chart TSX:AC) third quarter financials due Wednesday, analyst Corey Hammill of Paradigm Capital thinks the airline will manage a consensus beat on EBITDA, which should cause a jump in AC’s share price.

Air Canada’s stock has had an up-and-down year so far, rising 11 per cent between early January and late March but then losing all of that ground over subsequent months. It’s currently trading down nine per cent for the year.

Hammill says that based on quarterly reporting from the major US carriers, strong passenger demand and fee increases are likely to offset fuel increases for Air Canada.

“We remain upbeat in our outlook for AC and believe that a multiple expansion is more than overdue. The current spread between AC and US legacy carriers based on 2019 consensus EBITDAR estimates is two multiple points, with AC trading near 4x and US peers ~5.5x. We estimate that each one multiple point is worth ~$12/AC share. Investors should continue to watch the oil price closely, as this could have a material impact on estimates,” Hammill says.

“We expect AC is likely to beat Street EBITDA estimates, which should in turn lead to a boost to the share price,” he says. “The caveat is general market volatility.”

For the third quarter, the analyst projects revenue of $5.44 billion, representing an 11.4 per cent year-over-year growth (the consensus is $5.39 billion) and EBITDAR of $1.25 billion, representing a negative 9.7 per cent year-over-year decline (the consensus is $1.28 billion).

Hammill is maintaining his “Buy” rating and 12-month price target of $32.00, representing a projected return of 25 per cent at the time of publication.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: ac
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

It’s time to buy cannabis stocks, this analyst says

A major development came down the pipe this week at the U.S. Drug Enforcement Agency has reportedly decided to reschedule… [Read More]

4 hours ago

Is Generac stock a buy?

Following the company's first quarter results, Roth MKM analyst Chip Moore remains neutral on Generac Holdings (Generac Holdings Stock Quote,… [Read More]

15 hours ago

Bombardier is a buy, Desjardins says (May, 2024)

The stock has climbed slowly but surely since last October. But is there still money to be made on Bombardier?… [Read More]

16 hours ago

Should you buy AMZN? (May, 2024)

Following the company's first quarter results, Roth MKM analyst Rohit Kulkarni has maintained his "Buy" rating on Amazon (Amazon Stock… [Read More]

1 day ago

These cannabis stocks will benefit most from reclassification

It happened. The move that everyone in the cannabis sector was hoping for came about swiftly on the last day… [Read More]

2 days ago

Is AMD stock a buy? (May, 2024)

Following the company's first quarter results, Roth MKM analyst Suji Desilva has maintained his "Buy" rating on Advanced Micro Devices… [Read More]

2 days ago